Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues ; volume:41 ; number:01 ; year:2021 ; pages:035-041
Hämostaseologie ; 41, Heft 01 (2021), 035-041
- Contributor
-
Beyer-Westendorf, Jan
- DOI
-
10.1055/a-1329-2430
- URN
-
urn:nbn:de:101:1-2021032717120618334517
- Rights
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beyer-Westendorf, Jan
Other Objects (12)
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Atrial fibrillation
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Atrial fibrillation
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Atrial fibrillation